IL110845A - History of pyridazine or their salts, methods for their preparation and anti-shock preparations containing them - Google Patents

History of pyridazine or their salts, methods for their preparation and anti-shock preparations containing them

Info

Publication number
IL110845A
IL110845A IL11084594A IL11084594A IL110845A IL 110845 A IL110845 A IL 110845A IL 11084594 A IL11084594 A IL 11084594A IL 11084594 A IL11084594 A IL 11084594A IL 110845 A IL110845 A IL 110845A
Authority
IL
Israel
Prior art keywords
group
substituted
hydrogen atom
formula
pyridyl
Prior art date
Application number
IL11084594A
Other languages
English (en)
Hebrew (he)
Other versions
IL110845A0 (en
Original Assignee
Ishihira Sangyo Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ishihira Sangyo Kaisha Ltd filed Critical Ishihira Sangyo Kaisha Ltd
Publication of IL110845A0 publication Critical patent/IL110845A0/xx
Publication of IL110845A publication Critical patent/IL110845A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL11084594A 1993-09-06 1994-09-02 History of pyridazine or their salts, methods for their preparation and anti-shock preparations containing them IL110845A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24634493 1993-09-06
JP8799994 1994-04-01

Publications (2)

Publication Number Publication Date
IL110845A0 IL110845A0 (en) 1994-11-28
IL110845A true IL110845A (en) 1999-01-26

Family

ID=26429218

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11084594A IL110845A (en) 1993-09-06 1994-09-02 History of pyridazine or their salts, methods for their preparation and anti-shock preparations containing them

Country Status (12)

Country Link
US (1) US5763439A (fr)
EP (1) EP0717734B1 (fr)
KR (1) KR960704853A (fr)
CN (1) CN1056369C (fr)
AT (1) ATE173471T1 (fr)
AU (1) AU681694B2 (fr)
CA (1) CA2170637C (fr)
DE (1) DE69414716T2 (fr)
ES (1) ES2125474T3 (fr)
IL (1) IL110845A (fr)
TW (1) TW259787B (fr)
WO (1) WO1995007264A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750523A (en) * 1994-01-25 1998-05-12 Nissan Chemical Industries, Ltd. Pyridazinone derivatives
WO2000009488A1 (fr) * 1998-08-14 2000-02-24 Nihon Nohyaku Co., Ltd. Derives de pyridazinone
JP4711520B2 (ja) * 2000-03-21 2011-06-29 日本ケミカルリサーチ株式会社 生理活性ペプチド含有粉末
CN102532126B (zh) * 2012-02-10 2014-06-18 贵州大学 2-取代-4-氯-5-[5-取代胺基-2-(1,3,4-噻二唑基)-巯基]-3(2h)-哒嗪酮类衍生物及其制备方法和用途
CN104230902B (zh) * 2013-06-19 2017-05-10 中国科学院大连化学物理研究所 一类6,7‑二羟基香豆素衍生物、制备方法和应用
WO2023166067A1 (fr) 2022-03-02 2023-09-07 Syngenta Crop Protection Ag Dérivés microbiocides de pyridazinone amide
WO2024132895A1 (fr) 2022-12-19 2024-06-27 Syngenta Crop Protection Ag Composés microbiocides de dihydrooxadiazinyl pyridazinone
WO2024132901A1 (fr) 2022-12-19 2024-06-27 Syngenta Crop Protection Ag Dérivés microbiocides de pyridazine dihydrooxadiazine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1265798A (fr) * 1984-12-10 1990-02-13 Motoo Mutsukado 3(2h) pyridazinone, procede de preparation et agent anti-allergique le contenant
US4978665A (en) * 1987-01-20 1990-12-18 Nissan Chemical Industries Ltd. 3(2H)pyridazinone, and antagonistic agent against SRS-A containing it
JPH02256668A (ja) * 1988-12-20 1990-10-17 Nissan Chem Ind Ltd ピリダジノン誘導体
US5079261A (en) * 1989-04-28 1992-01-07 Brigham And Women's Hospital Use of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis
KR970002876B1 (ko) * 1990-04-25 1997-03-12 닛산가가꾸고오교 가부시끼가이샤 피리다지논 유도체

Also Published As

Publication number Publication date
ATE173471T1 (de) 1998-12-15
TW259787B (fr) 1995-10-11
AU7467694A (en) 1995-03-27
CN1130378A (zh) 1996-09-04
AU681694B2 (en) 1997-09-04
EP0717734B1 (fr) 1998-11-18
CA2170637A1 (fr) 1995-03-16
US5763439A (en) 1998-06-09
KR960704853A (ko) 1996-10-09
DE69414716T2 (de) 1999-04-08
CN1056369C (zh) 2000-09-13
DE69414716D1 (de) 1998-12-24
ES2125474T3 (es) 1999-03-01
CA2170637C (fr) 2005-01-25
IL110845A0 (en) 1994-11-28
WO1995007264A1 (fr) 1995-03-16
EP0717734A1 (fr) 1996-06-26

Similar Documents

Publication Publication Date Title
EP0482208B1 (fr) Derive de pyridazinone
CA2668592C (fr) Nouveau derive 1,2-dihydroquinoline comprenant un groupe alkyle inferieur phenylchalcogeno substitue et un groupe phenyle introduit par un ester en tant que substituants
KR20080102181A (ko) 스핑고신-1-포스페이트 (에스1피) 수용체 길항제 생물학적 활성을 갖는 아릴 또는 헤테로아릴기를 포함하는 인돌-3-카르보실산 아미드, 에스테르, 티오아미드 및 티올 에스테르 화합물
US4978665A (en) 3(2H)pyridazinone, and antagonistic agent against SRS-A containing it
EP1783116A1 (fr) Derive de 2-phenylpyridine
JP5635743B2 (ja) 置換オキシ基を有する２，２，４−トリメチル−６−フェニル−１，２−ジヒドロキノリン誘導体からなるグルココルチコイド受容体アゴニスト
BG97438A (bg) 4-алкилимидазолови съединения
US5763439A (en) Pyridazinone derivatives or their salts, processes for their production, and anti-shock agents containing them
WO2010029986A1 (fr) Agoniste de récepteur de glucocorticoïde comprenant un nouveau dérivé de 1,2,3,4-tétrahydroquinoxaline contenant un groupe phényle ayant une structure d’ester d’acide sulfonique introduite dans celui-ci en tant que substituant
US5236948A (en) Sulphonamide derivatives
TWI341838B (en) Carboxylic acid compound and pharmaceutical composition containg same as active ingredient
JP2006527706A (ja) セロトニン再取り込み阻害剤としてのインドール誘導体
JPS644518B2 (fr)
JPH05502235A (ja) イミダゾール類
JP3015702B2 (ja) イミダゾール誘導体及びそれらの薬剤として許容される酸付加塩及びその製造法並びにそれらを有効成分とする抗潰瘍剤
JPH05331164A (ja) アンジオテンシンｉｉ拮抗性イソインドール誘導体
JPH07316054A (ja) ピリダジノン誘導体またはその塩、それらの製造方法およびそれらを含有する抗ショック剤
JPH01121269A (ja) １−アシル−２，３−ジヒドロ−４（１ｈ）−キノリノン−４−オキシム誘導体、その製法およびそれらを主成分とする利尿、降圧、抗浮腫および腹水除去用医薬組成物
JP4759207B2 (ja) １−（ベンゾチアゾール−２−イル）ピラゾール誘導体およびそれを含有するｃｏｘ−２阻害剤
US5171857A (en) Antihypertensive benzopyran derivatives
US5258399A (en) Sulphonamide derivatives
TWI224099B (en) Benzopyran derivatives and antiallergic agent
JP3038032B2 (ja) 血小板凝集抑制薬
JPH02247174A (ja) 抗炎症性１―ヘテロアリール―オキシインドール―３―カルボキサミド
JP2022029881A (ja) ヘテロアリールで置換されたピリジン化合物を有効成分として含有する医薬

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees